Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike ...

(MENAFN- The Rio Times) Novo Nordisk, the Danish pharmaceutical leader ... into enzyme production for semaglutide-based drugs like Ozempic and Wegovy. The company's decision underscores Brazil's ...

The Montes Claros site in Brazil is just one of many that Novo Nordisk has poured billions of dollars into as part of efforts ...

Eli Lilly plans to manufacture its new weight-loss pill in the US for patients around the world as Trump presses companies to ...

Current developments in the health sector include Novo Nordisk's warning about counterfeit Ozempic in the US, Sandoz's antitrust lawsuit against Amgen, and rising concerns in the biotech industry due ...

Trump previously floated a 25% tariff on all imported drugs, though they were unaffected by recent reciprocal levies.

The US Food and Drug Administration (FDA) on Monday urged patients and healthcare providers to verify the authenticity of ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

Ozempic, a medication to help manage diabetes, has shot up in popularity in the US. So much so, that the US Food and Drug Administration (FDA) has issued a warning against using counterfeit Ozempic, ...